Related Experiment Videos
Purification and characterization of human recombinant precursor interleukin 1 beta
1Department of Molecular Genetics, Smith Kline and French Laboratories, King of Prussia, Pennsylvania 19406-0930.
The Journal of Biological Chemistry
|January 25, 1989
Summary
The inactive precursor of human interleukin 1 beta (proIL1 beta) can be activated by proteolysis. Specific cleavage by chymotrypsin fully restores biological and receptor binding activity, highlighting the role of the pro-region in regulating IL-1 beta function.
Area of Science:
- Immunology
- Molecular Biology
- Protein Chemistry
Background:
- Human interleukin 1 beta (IL-1 beta) is a key inflammatory cytokine.
- The precursor form (proIL1 beta) is biologically inactive.
- Understanding proIL1 beta regulation is crucial for controlling inflammatory responses.
Purpose of the Study:
- To characterize the recombinant human proIL1 beta.
- To investigate the mechanism of proIL1 beta activation.
- To determine the role of the pro-region in IL-1 beta activity and receptor binding.
Main Methods:
- Purification of recombinant proIL1 beta from Escherichia coli.
- Biochemical characterization using SDS-PAGE, spectroscopy, and Western blot.
- Assays for biological activity (EL4 thymoma assay) and receptor binding.
- Proteolytic cleavage studies with chymotrypsin and trypsin.
Main Results:
- Recombinant proIL1 beta was purified and characterized.
- ProIL1 beta showed minimal biological activity and did not bind the IL-1 receptor.
- Chymotrypsin cleavage generated a 17-kDa mature IL-1 beta with high activity, while trypsin yielded a partially active 22-kDa form.
- ProIL1 beta shares similar secondary structure (beta sheet) with mature IL-1 beta.
Conclusions:
- The pro-region of IL-1 beta directly inhibits both biological activity and IL-1 receptor binding.
- Proteolytic processing, particularly by chymotrypsin, is essential for activating proIL1 beta.
- The findings provide insights into the post-translational regulation of IL-1 beta.